» Articles » PMID: 9696871

Detection of a Trimeric Human Immunodeficiency Virus Type 1 Gag Intermediate is Dependent on Sequences in the Matrix Protein, P17

Overview
Journal J Virol
Date 1998 Aug 8
PMID 9696871
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have shown that single amino acid changes in the amino-terminal matrix (MA) domain, p17, of the human immunodeficiency virus type 1 Gag precursor Pr55, can abrogate virion particle assembly. In the three-dimensional structure of MA such mutations lie in a single helix spanning residues 54 to 68, suggesting a key role for this helix in the assembly process. The fundamental nature of this involvement, however, remains poorly understood. In the present study, the essential features of the MA helix required for virus assembly have been investigated through the analysis of a further 15 site-directed mutants. With previous mutants that failed to assemble, residues mapped as critical for assembly were all located on the hydrophobic face of the helix and had a key role in stabilizing the trimeric interface. This implies a role for the MA trimer in virus assembly. We support this interpretation by showing that purified MA is trimeric in solution and that mutations that prevent virus assembly also prevent trimerization. Trimerization in solution was also a property of a larger MA-capsid (CA) Gag molecule, while under the same conditions CA only was a monomer. These data suggest that Gag trimerization driven by the MA domain is an intermediate stage in normal virion assembly and that it relies, in turn, on an MA conformation dependent on the hydrophobic core of the molecule.

Citing Articles

Relationship between HIV-1 Gag Multimerization and Membrane Binding.

Sumner C, Ono A Viruses. 2022; 14(3).

PMID: 35337029 PMC: 8949992. DOI: 10.3390/v14030622.


Interaction Interface of Mason-Pfizer Monkey Virus Matrix and Envelope Proteins.

Prchal J, Sys J, Junkova P, Lipov J, Ruml T J Virol. 2020; 94(20).

PMID: 32796061 PMC: 7527036. DOI: 10.1128/JVI.01146-20.


Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions.

Alfadhli A, Staubus A, Tedbury P, Novikova M, Freed E, Barklis E J Virol. 2019; 93(21).

PMID: 31375589 PMC: 6803273. DOI: 10.1128/JVI.01079-19.


Dual Molecular Mechanisms Govern Escape at Immunodominant HLA A2-Restricted HIV Epitope.

Cole D, Fuller A, Dolton G, Zervoudi E, Legut M, Miles K Front Immunol. 2017; 8:1503.

PMID: 29209312 PMC: 5701626. DOI: 10.3389/fimmu.2017.01503.


Effect of Glu12-His89 Interaction on Dynamic Structures in HIV-1 p17 Matrix Protein Elucidated by NMR.

Konagaya Y, Miyakawa R, Sato M, Matsugami A, Watanabe S, Hayashi F PLoS One. 2016; 11(12):e0167176.

PMID: 27907055 PMC: 5132258. DOI: 10.1371/journal.pone.0167176.


References
1.
Smith D, Johnson K . Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene. 1988; 67(1):31-40. DOI: 10.1016/0378-1119(88)90005-4. View

2.
Momany C, Kovari L, Prongay A, Keller W, Gitti R, Lee B . Crystal structure of dimeric HIV-1 capsid protein. Nat Struct Biol. 1996; 3(9):763-70. DOI: 10.1038/nsb0996-763. View

3.
Massiah M, Worthylake D, Christensen A, Sundquist W, Hill C, Summers M . Comparison of the NMR and X-ray structures of the HIV-1 matrix protein: evidence for conformational changes during viral assembly. Protein Sci. 1996; 5(12):2391-8. PMC: 2143307. DOI: 10.1002/pro.5560051202. View

4.
Cannon P, Matthews S, Clark N, Byles E, Iourin O, Hockley D . Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17. J Virol. 1997; 71(5):3474-83. PMC: 191494. DOI: 10.1128/JVI.71.5.3474-3483.1997. View

5.
Zhang Y, Qian H, Love Z, Barklis E . Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain. J Virol. 1998; 72(3):1782-9. PMC: 109467. DOI: 10.1128/JVI.72.3.1782-1789.1998. View